RFG Advisory’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $985K | Sell |
9,525
-9,471
| -50% | -$845K | 0.02% | 580 |
|
|
2026
Q1 | $1.36M | Sell |
18,996
-3,002
| -14% | -$231K | 0.03% | 450 |
|
|
2025
Q4 | $1.75M | Buy |
21,998
+16,702
| +315% | +$1.32M | 0.03% | 367 |
|
|
2025
Q3 | $399K | Sell |
5,296
-502
| -9% | -$34.4K | 0.01% | 750 |
|
|
2025
Q2 | $400K | Sell |
5,798
-2,186
| -27% | -$143K | 0.01% | 707 |
|
|
2025
Q1 | $541K | Sell |
7,984
-273
| -3% | -$16.3K | 0.01% | 543 |
|
|
2024
Q4 | $371K | Sell |
8,257
-3,941
| -32% | -$221K | 0.01% | 593 |
|
|
2024
Q3 | $767K | Sell |
12,198
-4,033
| -25% | -$235K | 0.02% | 413 |
|
|
2024
Q2 | $959K | Buy |
16,231
+2,149
| +15% | +$134K | 0.03% | 354 |
|
|
2024
Q1 | $1.12M | Sell |
14,082
-461
| -3% | -$35.2K | 0.04% | 329 |
|
|
2023
Q4 | $1.15M | Sell |
14,543
-1,378
| -9% | -$98.1K | 0.04% | 299 |
|
|
2023
Q3 | $1.11M | Sell |
15,921
-1,624
| -9% | -$115K | 0.05% | 262 |
|
|
2023
Q2 | $1.21M | Sell |
17,545
-1,813
| -9% | -$129K | 0.05% | 252 |
|
|
2023
Q1 | $1.44M | Sell |
19,358
-2,364
| -11% | -$198K | 0.07% | 206 |
|
|
2022
Q4 | $1.86M | Sell |
21,722
-9,666
| -31% | -$933K | 0.09% | 164 |
|
|
2022
Q3 | $3.19M | Sell |
31,388
-1,163
| -4% | -$115K | 0.18% | 107 |
|
|
2022
Q2 | $3.33M | Buy |
32,551
+14,835
| +84% | +$1.45M | 0.19% | 92 |
|
|
2022
Q1 | $1.79M | Sell |
17,716
-1,321
| -7% | -$139K | 0.11% | 121 |
|
|
2021
Q4 | $1.96M | Buy |
19,037
+1,244
| +7% | +$115K | 0.13% | 105 |
|
|
2021
Q3 | $1.51M | Sell |
17,793
-547
| -3% | -$45.8K | 0.12% | 124 |
|
|
2021
Q2 | $1.53M | Sell |
18,340
-230
| -1% | -$18.8K | 0.14% | 121 |
|
|
2021
Q1 | $1.4M | Sell |
18,570
-551
| -3% | -$40.1K | 0.15% | 111 |
|
|
2020
Q4 | $1.43M | Buy |
19,121
+745
| +4% | +$48.5K | 0.19% | 103 |
|
|
2020
Q3 | $1.07M | Buy |
18,376
+6,547
| +55% | +$407K | 0.15% | 127 |
|
|
2020
Q2 | $769K | Buy |
11,829
+4,837
| +69% | +$305K | 0.12% | 157 |
|
|
2020
Q1 | $415K | Sell |
6,992
-208
| -3% | -$13.9K | 0.08% | 204 |
|
|
2019
Q4 | $535K | Buy |
7,200
+503
| +8% | +$35.3K | 0.09% | 191 |
|
|
2019
Q3 | $422K | Buy |
6,697
+1,177
| +21% | +$69.7K | 0.08% | 184 |
|
|
2019
Q2 | $300K | Buy |
+5,520
| New | +$297K | 0.07% | 235 |
|
|
2018
Q4 | – | Sell |
-2,773
| Closed | -$218K | – | 269 |
|
|
2018
Q3 | $218K | Buy |
+2,773
| New | +$198K | 0.06% | 271 |
|
|
2018
Q1 | – | Sell |
-2,796
| Closed | -$217K | – | 197 |
|
|
2017
Q4 | $217K | Sell |
2,796
-261
| -9% | -$19K | 0.1% | 171 |
|
|
2017
Q3 | $227K | Sell |
3,057
-31
| -1% | -$2.45K | 0.14% | 145 |
|
|
2017
Q2 | $241K | Sell |
3,088
-96
| -3% | -$7.58K | 0.17% | 121 |
|
|
2017
Q1 | $245K | Buy |
3,184
+501
| +19% | +$40K | 0.19% | 117 |
|
|
2016
Q4 | $231K | Hold |
2,683
| – | – | 0.22% | 77 |
|
|
2016
Q3 | $232K | Hold |
2,683
| – | – | 0.21% | 78 |
|
|
2016
Q2 | $257K | Sell |
2,683
-50
| -2% | -$4.98K | 0.22% | 75 |
|
|
2016
Q1 | $284K | Buy |
2,733
+215
| +9% | +$20.9K | 0.22% | 74 |
|
|
2015
Q4 | $246K | Buy |
+2,518
| New | +$247K | 0.18% | 47 |
|
|
2015
Q3 | – | Sell |
-2,411
| Closed | -$253K | – | 72 |
|
|
2015
Q2 | $253K | Buy |
+2,411
| New | +$246K | 0.11% | 131 |
|
Other funds holding CVS
RFG Advisory's CVS Position: Q2 2026 in Review
RFG Advisory reduced its CVS Health (CVS) stake by 50% in Q2 2026, selling an estimated $845K and leaving 9,525 shares worth $985K. The position accounts for 0.02% of the portfolio, ranked #580.
RFG Advisory first reported a position in CVS in Q2 2015 and has held it in 40 quarters since. The position peaked at $3.33M in Q2 2022. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- RFG Advisory held 9,525 shares of CVS Health worth $985K as of Q2 2026.
- RFG Advisory sold 9,471 CVS Health shares in Q2 2026, an estimated $845K.
- CVS Health made up 0.02% of RFG Advisory's portfolio in Q2 2026, its #580 holding.
- RFG Advisory first reported a position in CVS Health in Q2 2015 and has held it in 40 quarters since.
- RFG Advisory's CVS Health position peaked at $3.33M in Q2 2022.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on RFG Advisory's 13F filing for Q2 2026, filed 15 Jul 2026.